SECTOR ANALYSIS

Immunology Oncology Biotech Companies

Grades, scores, and FDA catalyst signals for Immunology Oncology stocks tracked by BiotechSign

← Full ScreenerFDA CalendarAll Sectors
Companies
47
Avg Score
42
Top Grade
C
Immunology Oncology Companies— 47 tracked
TickerCompanyScoreGradeSectorSignals
BGNEBeiGene Ltd63COncology—
DCPHDeciphera Pharmaceuticals63COncology—
TOIThe Oncology Institute, Inc.61COncology—
KURAKura Oncology, Inc.61COncology—
MGNXMacroGenics Inc59COncology—
CABACabaletta Bio59CImmunology—
CELCCelcuity Inc58COncology—
NKTRNektar Therapeutics58CImmunology—
SNDXSyndax Pharmaceuticals58COncology—
ALXOALX Oncology57COncology—
RIGLRigel Pharmaceuticals56CImmunology—
NUVBNuvation Bio56COncology—
TGTXTG Therapeutics55COncology—
EXELExelixis Inc54COncology—
BPMCBlueprint Medicines53COncology—
INCYIncyte Corporation52COncology—
ABBVAbbVie Inc52CImmunology—
SNYSanofi SA51CImmunology—
BMYBristol-Myers Squibb51COncology—
GERNGeron Corporation48DOncology—
LBPHLongboard Pharmaceuticals47DOncology—
ITOSiTeos Therapeutics44DOncology—
CRBPCorbus Pharmaceuticals43DOncology—
ZNTLZentalis Pharmaceuticals40DOncology—
ONCYOncolytics Biotech, Inc.39DOncology—
CRDFCardiff Oncology, Inc.38DOncology—
CGONCG Oncology, Inc.38DOncology—
AIMAIM ImmunoTech Inc.37DImmunology—
CRVSCorvus Pharmaceuticals37DOncology—
BBIOBridgeBio Pharma36DOncology—
NUVLNuvalent Inc35DOncology—
KPTIKaryopharm Therapeutics35FOncology—
CATXPerspective Therapeutics34FOncology—
BCABBioAtla Inc33FOncology—
ERASErasca Inc30FOncology—
LTRNLantern Pharma29FOncology—
PYXSPyxis Oncology, Inc.27FOncology—
ALPNAlpine Immune Sciences27FImmunology—
CDTXCidara Therapeutics26FOncology—
IMNMImmunome, Inc.26FImmunology—
FUSNFusion Pharmaceuticals24FOncology—
CGEMCullinan Oncology24FOncology—
APGEApogee Therapeutics23FImmunology—
ANABAnaptysBio Inc22FImmunology—
ESLAEstrella Immunopharma, Inc.21FImmunology—
LEGNLegend Biotech20FOncology—
BPTHBio-Path Holdings19FOncology—
Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSign grades and scores are algorithmic signals only and do not constitute investment recommendations. Biotech investing involves significant risk, including the potential for complete loss of capital on binary FDA events. Always conduct your own due diligence before making investment decisions.